REVOLUTIONIZING PSYCHIATRIC CARE: DR. ROBERT C. HIEMSTRA RELEASES EXPANDED EDITION 'KISSD 2: KETAMINE CONFIDENTIAL'

Board-certified emergency medicine physician Dr. Robert C. Hiemstra has announced the release of his updated and expanded medical guide, KISSD 2: KETAMINE CONFIDENTIAL https://www.amazon.com/dp/B0HJKBXG59. Building upon the groundwork of the original KISSD: Ketamine Intramuscular Stepped System for Depression released four years ago, this comprehensive new printing introduces critical new chapters addressing the rapidly evolving landscapes of clinical depression treatment and therapeutic ketamine protocols. Designed as an academic-yet-practical roadmap, the book equips medical professionals with a safe, effective recipe for evaluating patient depression status and assessing readiness for ketamine therapy-currently the only prescribed psychedelic medicine in America. Through a targeted digital press release campaign, Dr. Hiemstra's updated work is establishing high-authority search visibility across major news syndicates and Google News, offering a vital resource for practitioners navigating novel mental health interventions.

Challenging Traditional Psychiatry with Evidence-Based Innovation

Dr. Robert C. Hiemstra's https://www.amazon.com/dp/B0HJKBXG59 pioneering work with ketamine began in 2017 following a distinguished career practicing in emergency rooms across the nation and internationally. Recognizing a major gap in standardized clinical literature regarding ketamine's unique treatment parameters and side-effect profiles, he dedicated his practice to establishing clear, safe guidelines for its administration. Outside of his medical work, Dr. Hiemstra is an avid surfer, skier, and reader whose clinical insights are driven by a commitment to patient-first medical advocacy.

"The history of psychiatry and depression treatment has too often prioritized institutional inertia over patient recovery," Dr. Hiemstra observes regarding his motivation for the expanded edition. "We are talking about severe depression-arguably one of the most debilitating conditions a human being can experience. This book exists to provide clinicians with a precise, actionable framework to safely deliver a therapy that can truly transform lives." As this updated edition reaches medical professionals nationwide, Dr. Hiemstra's rigorous protocol stands as a critical bridge between cutting-edge pharmacological research and daily clinical practice.

KISSD 2: KETAMINE CONFIDENTIAL https://www.amazon.com/dp/B0HJKBXG59 is self-published by Dr. Robert C. Hiemstra and is available now on its official Amazon Marketplace Page and through major book distributors.

About the Author

Dr. Robert C. Hiemstra https://www.amazon.com/dp/B0HJKBXG59 is a board-certified emergency medicine physician with extensive global clinical experience. Since 2017, he has been at the forefront of research and clinical application for ketamine therapy in treatment-resistant depression. An advocate for medical transparency and therapeutic innovation, Dr. Hiemstra balances his clinical writing with a passion for outdoor pursuits including surfing and skiing. He continues to utilize targeted media syndication and scientific publishing to educate healthcare providers on safe, effective psychedelic-assisted protocols.

13312 Ranchero Rd., Ste 18-248
Oak Hills, CA, 92344

About Authors Perspective Press

Authors Perspective Press (APP) https://authorsperspectivepress.com is a marketing and advertising company based in California. Founded by passionate professionals with over 20 years of combined experience in publishing and book marketing, the company provides an effective platform and support for self-published authors. We offer a wide range of services, from publishing to marketing and advertising, with a continuous commitment to supporting our authors every step of the way.

This release was published on openPR.